CA992959A - O-triazenobenzamides, compositions, use and preparation thereof - Google Patents

O-triazenobenzamides, compositions, use and preparation thereof

Info

Publication number
CA992959A
CA992959A CA174,508A CA174508A CA992959A CA 992959 A CA992959 A CA 992959A CA 174508 A CA174508 A CA 174508A CA 992959 A CA992959 A CA 992959A
Authority
CA
Canada
Prior art keywords
triazenobenzamides
compositions
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA174,508A
Other versions
CA174508S (en
Inventor
John T. O'brien
Zaven S. Ariyan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UNIROYAL
Original Assignee
UNIROYAL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UNIROYAL filed Critical UNIROYAL
Application granted granted Critical
Publication of CA992959A publication Critical patent/CA992959A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/76Nitrogen atoms to which a second hetero atom is attached
    • C07D213/77Hydrazine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/50Nitrogen atoms bound to hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA174,508A 1972-12-04 1973-06-20 O-triazenobenzamides, compositions, use and preparation thereof Expired CA992959A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31187872A 1972-12-04 1972-12-04

Publications (1)

Publication Number Publication Date
CA992959A true CA992959A (en) 1976-07-13

Family

ID=23208914

Family Applications (1)

Application Number Title Priority Date Filing Date
CA174,508A Expired CA992959A (en) 1972-12-04 1973-06-20 O-triazenobenzamides, compositions, use and preparation thereof

Country Status (4)

Country Link
JP (1) JPS4986520A (en)
CA (1) CA992959A (en)
DE (1) DE2359775A1 (en)
FR (1) FR2208666A1 (en)

Also Published As

Publication number Publication date
FR2208666A1 (en) 1974-06-28
JPS4986520A (en) 1974-08-19
DE2359775A1 (en) 1974-06-12

Similar Documents

Publication Publication Date Title
CA1006285A (en) Polyureas and preparation thereof
CA945179A (en) Catalyst compositions, their preparation and use
CA1010862A (en) N-hexamethylene-imino-alkyl derivatives, and their preparation
AU467736B2 (en) Pteridinones and the preparation thereof
CA991650A (en) Chromium (iii) compositions, their preparation and use
CA992959A (en) O-triazenobenzamides, compositions, use and preparation thereof
AU466441B2 (en) New cyclopentenoquinolone derivatives and the preparation thereof
CA902628A (en) Silylorganocarbamates and preparation
CA904346A (en) 3,4,5-trialkoxybenzamides and preparation
AU487253B2 (en) New 2b, 16b-diamino-androstanes and their preparation
AU5815373A (en) Compositions and methods
CA875539A (en) N6-aralkyl-adenosine derivatives, preparation and compositions thereof
IL39402A0 (en) 8-hydroxyerythromycin and derivatives thereof,the preparation thereof,and compositions comprising the same
CA897173A (en) N-hydroxy-benzimidazoles, their preparation and use as herbicides
AU459016B2 (en) Perfluoroalkylarylamines, their preparation and use
CA914197A (en) 1,2-dicyano-3,5-dithio-4-sulfonylimido cyclopentenes, and preparation and use thereof
AU6286273A (en) New 2b, 16b-diamino-androstanes and their preparation
CA895335A (en) Perfluoroperoxyhypochlorites and preparation thereof
CA891528A (en) N-acylbenzohydroxamate and preparation thereof
AU483281B2 (en) Phthalidides and preparation thereof
CA961507A (en) Cement compositions and the preparation thereof
AU482409B2 (en) ALKYL-6, 7-DIALKOXY-2-METHYL-4-OXOTETRAHYDRODUINOLINE-l-CARBOXYLATES AND THEIR PREPARATION
CA912590A (en) Catalytic compositions and uses thereof
AU463850B2 (en) 13-ethyl-16-hydroxymethylene-1,3,5 [10] gonatriene-3-ol-17-one and its preparation
CA906128A (en) Aminooxyorganopolysiloxanes and preparation